Skip to main content
. 2022 Jan 19;52(2):68–74. doi: 10.1016/j.idnow.2022.01.004

Fig. 3.

Fig. 3

A. SARS-CoV-2 anti-nucleocapsid and B. Anti-spike IgG antibody evolution for the whole cohort. (S1 = day 0, S2 = month 1 or day 30, S3 = month 3 or day 90, S4 = month 8 or day 210) (n = 74).